BioTrinity 2024 | Glue Up | 22 April 2024 | TBA, London, UK

This event is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The delegate mix comprises early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.

After the sell-out success of BioTrinity 2023, OBN are pleased to announce the 2024 edition will be hosted in a larger capacity venue, etc. venues 133 Houndsditch in London. The move will allow us to deliver an enhanced format, in a more spacious environment, whilst ensuring we continue to catalyse success for all who attend.

Key changes for 2024 include:

• An increase in audience size of c.15%
• More spacious partnering area
• Three tracks of presentations; two science focused and one business/investment focused, with each track incorporating more breaks and added time for questions with speakers
• Plenty of informal seating space for delegates to catch up on calls and take impromptu meetings
• An all-delegate networking party on-site at the conference venue on Tuesday 23 April, included in the delegate ticket price

Additional conference features include:

• Scientific spotlight presentations from Series A stage companies across Oncology, Neuroscience, Microbiome, Inflammatory Diseases, Rare Diseases, Infectious Diseases, Medtech, AI & Drug Discovery, Ageing, Cell & Gene Therapy and more
• Two days of pre-scheduled in-person private partnering meetings and a bonus virtual third day
• An enhanced sponsors exhibition
• Two-days of catering for all delegates, including the new all-delegate networking evening on Tuesday 23 April
• Access to digital content from the business track, and presentations from the scientific sessions